GAMBACORTI PASSERINI, CARLO
 Distribuzione geografica
Continente #
NA - Nord America 1.227
EU - Europa 516
AS - Asia 133
AF - Africa 16
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 1.904
Nazione #
US - Stati Uniti d'America 1.203
IT - Italia 167
FR - Francia 83
DE - Germania 70
CN - Cina 58
IE - Irlanda 44
CZ - Repubblica Ceca 35
RU - Federazione Russa 28
CA - Canada 19
GB - Regno Unito 19
JP - Giappone 17
UA - Ucraina 17
FI - Finlandia 12
NL - Olanda 11
IN - India 10
ZA - Sudafrica 10
VN - Vietnam 9
CL - Cile 8
SG - Singapore 7
HK - Hong Kong 6
AE - Emirati Arabi Uniti 5
MX - Messico 5
PT - Portogallo 5
TR - Turchia 5
BG - Bulgaria 4
EG - Egitto 3
ES - Italia 3
GH - Ghana 3
IL - Israele 3
KR - Corea 3
LB - Libano 3
RO - Romania 3
RS - Serbia 3
SE - Svezia 3
HU - Ungheria 2
TH - Thailandia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AT - Austria 1
AU - Australia 1
BE - Belgio 1
BR - Brasile 1
DK - Danimarca 1
EU - Europa 1
ID - Indonesia 1
JO - Giordania 1
MK - Macedonia 1
NO - Norvegia 1
PK - Pakistan 1
SI - Slovenia 1
Totale 1.904
Città #
Santa Cruz 166
Fairfield 118
Ashburn 75
Houston 60
Buffalo 58
Seattle 57
Woodbridge 50
Milan 48
Cambridge 44
Dublin 44
Frankfurt am Main 44
Wilmington 31
Chicago 26
Ann Arbor 24
Boardman 18
Los Angeles 16
Beijing 15
Palo Alto 14
Shanghai 14
Helsinki 12
Las Vegas 11
Mountain View 11
Henderson 9
Andover 8
Carate Brianza 8
Clearwater 8
Muizenberg 8
New York 8
Rome 8
San Francisco 8
Toronto 8
Wuhan 8
Ottawa 7
Phoenix 7
Dong Ket 6
San Diego 6
Paris 5
Saint Petersburg 5
San Jose 5
Torino 5
Bologna 4
Dallas 4
Des Moines 4
Hangzhou 4
Lake Forest 4
Meda 4
Modena 4
Parsippany 4
Pasadena 4
Portland 4
Redmond 4
Rio de Mouro 4
Riva 4
Rockville 4
Seriate 4
Amsterdam 3
Auburn 3
Büdelsdorf 3
Central 3
Chennai 3
Council Bluffs 3
Kragujevac 3
London 3
Monza 3
Provo 3
Singapore 3
University Park 3
Ahi'ezer 2
Boston 2
Bovisio-Masciago 2
Boyds 2
Casorate Primo 2
Cesena 2
Collegeville 2
Columbia 2
Columbus 2
Frankfurt Am Main 2
Hanoi 2
Herndon 2
Hillsboro 2
Izmir 2
Jamaica Plain 2
Jersey City 2
Jönköping 2
Lombard 2
Mexico 2
Miami 2
Ningbo 2
Padova 2
Pavia 2
Piemonte 2
Providence 2
Riva del Garda 2
Santiago 2
Sassari 2
Seveso 2
Silverton 2
Sofia 2
Tampa 2
Turin 2
Totale 1.245
Nome #
Tumor Resistance against ALK Targeted Therapy-Where It Comes From and Where It Goes, file e39773b4-fcf0-35a3-e053-3a05fe0aac26 248
De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways, file e39773b6-139c-35a3-e053-3a05fe0aac26 169
Concomitant BCORL1 and BRAF Mutations in Vemurafenib-Resistant Melanoma Cells, file e39773b4-fcf3-35a3-e053-3a05fe0aac26 136
Mitochondrial Hyperactivation and Enhanced ROS Production are Involved in Toxicity Induced by Oncogenic Kinases Over-Signaling, file e39773b5-3a31-35a3-e053-3a05fe0aac26 124
An Imatinib–non-responsive patient with an ABL Leu387Trp mutation achieves cytogenetic and molecular response under bosutinib: Case report and biological characterization, file e39773b6-422d-35a3-e053-3a05fe0aac26 110
C-MYC generates repair errors via increased transcription of alternative-NHEJ factors, LIG3 and PARP1, in tyrosine kinase-activated leukemias, file e39773b7-9374-35a3-e053-3a05fe0aac26 106
OncoScore: A novel, Internet-based tool to assess the oncogenic potential of genes, file e39773b3-cf4a-35a3-e053-3a05fe0aac26 105
Erratum: Identification of 4-Phenoxyquinoline Based Inhibitors for L1196M Mutant of Anaplastic Lymphoma Kinase by Structure-Based Design (Journal of Medicinal Chemistry (2017) 60:22 (9205-9221) DOI: 10.1021/acs.jmedchem.7b01039), file e39773b7-9325-35a3-e053-3a05fe0aac26 101
ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine, file e39773b7-0979-35a3-e053-3a05fe0aac26 99
Long-term and low-dose of busulfan is a safe and effective second-line treatment in elderly patients with essential thrombocythemia resistant or intolerant to hydroxyurea, file e39773b7-9caf-35a3-e053-3a05fe0aac26 57
Effects of Bosutinib Treatment on Renal Function in Patients With Philadelphia Chromosome-Positive Leukemias, file e39773b7-9e5c-35a3-e053-3a05fe0aac26 57
Erratum: OncoScore: a novel, Internet-based tool to assess the oncogenic potential of genes, file e39773b7-9e90-35a3-e053-3a05fe0aac26 56
NPM/ALK mutants resistant to ASP3026 display variable sensitivity to alternative ALK inhibitors but succumb to the novel compound PF-06463922, file e39773b7-9373-35a3-e053-3a05fe0aac26 55
SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub, file e39773b7-9cb0-35a3-e053-3a05fe0aac26 54
β-catenin knockdown promotes NHERF1-mediated survival of colorectal cancer cells: Implications for a double-targeted therapy, file e39773b7-8f55-35a3-e053-3a05fe0aac26 53
Treatment patterns in patients with chronic-phase chronic myeloid leukaemia in routine clinical practice: The simplicity Italian population, file e39773b7-8643-35a3-e053-3a05fe0aac26 51
In vitro and in vivo identification of ABCB1 as an efflux transporter of bosutinib, file e39773b7-9375-35a3-e053-3a05fe0aac26 50
Telomere length shortening is associated with treatment-free remission in chronic myeloid leukemia patients, file e39773b7-98a0-35a3-e053-3a05fe0aac26 49
Management of adverse events associated with bosutinib treatment of chronic-phase chronic myeloid leukemia: Expert panel review, file e39773b7-9cb1-35a3-e053-3a05fe0aac26 49
The novel PIM1 inhibitor NMS-P645 reverses PIM1-Dependent effects on TMPRSS2/ERG positive Prostate cancer cells and shows anti-proliferative activity in combination with PI3K inhibition, file e39773b7-a222-35a3-e053-3a05fe0aac26 38
Effects of blocking CD24 and CD47 'don't eat me' signals in combination with rituximab in mantle-cell lymphoma and chronic lymphocytic leukaemia, file 5c471a21-cb11-4602-b96a-0a53c519def4 21
Evaluating the performance of large language models in haematopoietic stem cell transplantation decision-making, file 186fdd3e-b6a4-4d43-a4b3-a594adcb8d1b 20
Tixagevimab/Cilgavimab Pre-exposure Prophylaxis in Patients with Lymphoproliferative Disorders on BTKi, file ea09c0e1-ca76-4b9e-834a-6874da71604d 20
Humoral and cellular immune response in patients with hematological disorders after two doses of BNT162b2 mRNA COVID-19 vaccine: A single-center prospective observational study (NCT05074706), file 5e456eae-4aaf-4615-9e27-02321f774770 18
Treatment efficacy and resistance mechanisms using the second-generation ALK inhibitor AP26113 in human NPM-ALK-positive anaplastic large cell lymphoma, file e39773b8-3fbd-35a3-e053-3a05fe0aac26 18
A monocentric analysis of the long-term safety and efficacy of crizotinib in relapsed/refractory ALK+ lymphomas, file 01194b51-9a89-4815-a965-374df2b4d001 16
Clinical and Molecular features of the patients with Idiopathic Erythrocytosis, file 60a40a1a-ab28-49e1-b4bc-bef3be2527e9 16
DNA Damage Response (DDR) Is Associated With Treatment-free Remission in Chronic Myeloid Leukemia Patients, file b855450f-18eb-4067-8058-69e351baea67 16
Role of somatic ETNK1 mutation in the mitochondrial activity, file ef4a1648-0924-4018-a701-bdda2b9ff6ab 13
Paired Exome Sequencing Reveals Recurrent Germline Variants in Patients with Idiopathic Erythrocytosis, file b5666ee7-44e0-40dd-bd1b-a5c9f0c00adc 12
ETNK1 mutations increase mitochondrial activity and promote DNA damage through ROS production, file 30d742f6-63f3-4923-9f68-cb5561134d7a 9
Characterization of the transcriptional landscape of atypical Chronic Myeloid Leukemia at single-cell resolution, file 57c08b4e-905c-4d0c-96de-63ce45b2e3d0 7
Idiopathic erythrocytosis: a germline disease?, file 9c8c1c9f-8c8d-4f91-a1c2-311e6a64229b 5
Late relapse of chronic myeloid leukemia after allogeneic bone marrow transplantation points to KANSARL (KANSL1::ARL17A) alteration: a case report with insights on the molecular landscape, file f7014caf-69d5-48e6-ab35-349be2506e83 5
Secondary infections worsen the outcome of COVID-19 in patients with hematological malignancies: A report from the ITA-HEMA-COV, file 12fdcfce-2c4d-45b2-ad91-cd500d2845c0 4
Lorlatinib treatment elicits multiple on- and off-target mechanisms of resistance in ALK-driven cancer, file e39773b8-4de8-35a3-e053-3a05fe0aac26 4
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis, file 118763bb-674c-4c98-962d-7f8ddf14cd64 3
Synergistic drug combinations preventdrug resistance in anaplastic large cell lymphomapreclinical models, file 473ea030-9297-4dc8-a1fb-d01126092e55 3
BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene, file e39773b2-9e94-35a3-e053-3a05fe0aac26 2
SARS-CoV-2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID-19 cohort, file fdb67b90-16cc-40ad-8b54-787d43b8b484 2
Totale 1.981
Categoria #
all - tutte 5.933
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.933


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201958 0 0 0 0 0 0 0 0 0 12 25 21
2019/2020147 15 7 8 9 11 12 15 14 19 19 11 7
2020/2021309 12 17 13 11 11 13 63 28 35 38 49 19
2021/2022564 28 25 25 30 43 31 34 38 48 32 174 56
2022/2023520 35 48 146 71 16 21 13 28 52 20 39 31
2023/2024348 14 14 24 38 29 56 70 33 42 28 0 0
Totale 1.981